Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug targeting of dysregulated transcription in Huntington's disease.

Drug targeting of dysregulated transcription in Huntington's disease. Prog Neurobiol. 2007 Nov; 83(4):249-59.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.